DGAP-News Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years

Nachrichtenquelle: EQS Group AG
24.11.2020, 07:30  |  119   |   |   

DGAP-News: Formycon AG / Key word(s): Personnel/Miscellaneous
Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years

24.11.2020 / 07:30
The issuer is solely responsible for the content of this announcement.


 



Press Release // November 24, 2020

Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years

Munich - The Supervisory Board of Formycon AG (ISIN: DE000A1EWVY8/ WKN: A1EWVY) has extended the appointment of Management Board member Dr. Stefan Glombitza as Chief Operating Officer (COO) until December 31, 2024. With this decision, the supervisory committee is honoring the Formycon manager's successful work over recent years, and providing the continuity needed at the head of the company.

Since October 1, 2016, Dr. Glombitza has been the COO of Formycon AG in charge of operational development activities and has since then played a leading role in the progress of Formycon AG's development projects. The initiatives for operational excellence, which were also initiated and successfully implemented under his responsibility, were and continue to be central building blocks of organizational development, making Formycon an outstanding and scalable development organization.

"In light of his outstanding achievements for the company, we are particularly pleased to extend Stefan Glombitza's appointment to the Management Board until the end of 2024. Thanks to his comprehensive expertise and his particular commitment, Mr. Glombitza has successfully advanced the further development of the individual biosimilar projects as well as the entire development organization in recent years. We are convinced that with Dr. Brockmeyer (CEO), Dr. Combé (CFO) and Dr. Glombitza (COO) we have established a strong leadership team at Formycon and look forward to continuing to work together," commented Dr. Olaf Stiller, Chairman of the Supervisory Board of Formycon AG.

Seite 1 von 3
Formycon Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

DGAP-News Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years DGAP-News: Formycon AG / Key word(s): Personnel/Miscellaneous Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years 24.11.2020 / 07:30 The issuer is solely responsible for the content of …

Nachrichten des Autors

Titel
Titel
Titel
Titel

COMMUNITY

ZeitTitel
19:14 Uhr